AU4435199A - Isoflavone derivatives - Google Patents

Isoflavone derivatives

Info

Publication number
AU4435199A
AU4435199A AU44351/99A AU4435199A AU4435199A AU 4435199 A AU4435199 A AU 4435199A AU 44351/99 A AU44351/99 A AU 44351/99A AU 4435199 A AU4435199 A AU 4435199A AU 4435199 A AU4435199 A AU 4435199A
Authority
AU
Australia
Prior art keywords
isoflavone derivatives
isoflavone
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU44351/99A
Inventor
Sheldon S Hendler
Jan Zielinski
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
374Water Inc
Original Assignee
Vyrex Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vyrex Corp filed Critical Vyrex Corp
Publication of AU4435199A publication Critical patent/AU4435199A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/655—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
    • C07F9/6552—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a six-membered ring
    • C07F9/65522—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a six-membered ring condensed with carbocyclic rings or carbocyclic ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/26—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
    • C07D311/34—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 3 only
    • C07D311/36—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 3 only not hydrogenated in the hetero ring, e.g. isoflavones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/26—Acyclic or carbocyclic radicals, substituted by hetero rings
AU44351/99A 1998-06-12 1999-06-10 Isoflavone derivatives Abandoned AU4435199A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US9856198P 1998-06-12 1998-06-12
US60098561 1998-06-12
PCT/US1999/013160 WO1999063995A1 (en) 1998-06-12 1999-06-10 Isoflavone derivatives

Publications (1)

Publication Number Publication Date
AU4435199A true AU4435199A (en) 1999-12-30

Family

ID=22269850

Family Applications (1)

Application Number Title Priority Date Filing Date
AU44351/99A Abandoned AU4435199A (en) 1998-06-12 1999-06-10 Isoflavone derivatives

Country Status (2)

Country Link
AU (1) AU4435199A (en)
WO (1) WO1999063995A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100436220B1 (en) * 2001-08-30 2004-06-12 주식회사 네패스 Organic polymers for bottom antireflective coating, processes for preparing the same, and compositions containing the same
GB0124842D0 (en) 2001-10-17 2001-12-05 Clariant Int Ltd Improvements relating to organic compounds
KR20060082790A (en) * 2003-06-20 2006-07-19 코그니스 프랑스 에스.에이.에스. ESTERS OF FLAVONOIDS WITH omega;-SUBSTITUTED C6-C22 FATTY ACIDS
JP2007511542A (en) * 2003-11-18 2007-05-10 ノボゲン リサーチ ピーティーワイ リミテッド Isoflavonoid prodrugs, compositions thereof, and therapeutic methods using them
AU2004290613B2 (en) * 2003-11-18 2010-03-25 Novogen Research Pty Ltd Isoflavonoid prodrugs, compositions thereof and therapeutic methods involving same
JP6473321B2 (en) * 2014-11-20 2019-02-20 株式会社ダイセル Method for producing phosphorylated equol using enzymes
US10881634B2 (en) * 2017-12-07 2021-01-05 Hughes Biotechnology Co., Ltd Method for treatment or prevention of a disease associated with a decrease in bone mass and method of improving bone architecture and bio mechanical strength of bone
JP6870011B2 (en) * 2019-01-25 2021-05-12 株式会社ダイセル Method for producing phosphorylated equol using an enzyme
JP2021080264A (en) * 2021-02-15 2021-05-27 株式会社ダイセル Method for producing phosphorylated equol using enzyme
WO2023212130A1 (en) * 2022-04-28 2023-11-02 GreenStone Biosciences, Inc. Treatment of the adverse cardiovascular effects of cannabinoids

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4166862A (en) * 1971-05-25 1979-09-04 Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Rt. Animal feed containing anabolic isoflavones
JPS62201882A (en) * 1985-11-18 1987-09-05 Yamanouchi Pharmaceut Co Ltd Isoflavon derivative

Also Published As

Publication number Publication date
WO1999063995A1 (en) 1999-12-16

Similar Documents

Publication Publication Date Title
AU6314900A (en) Biarylurea derivatives
AU6714700A (en) Cyclopropylindole derivatives
AU4922499A (en) Trioxane derivatives
IL139808A0 (en) Novel benzopyran or thiobenzopyran derivatives
AU7952800A (en) 2-alkoxybenzene derivatives
AU1379900A (en) Novel substituted phenyloxazolidone derivatives
AU5444499A (en) Benzoxazine derivatives
AU4435199A (en) Isoflavone derivatives
PL348191A1 (en) Chroman derivatives
AU3167699A (en) Vitamin d derivatives substituted at the 2beta-position
AU2830800A (en) Chroman derivatives
AU6228299A (en) 2-substituted-d-homooxasteroid derivatives
AU3534499A (en) Radicicol derivatives
AU2640999A (en) 1-azaindolizine derivatives
AU6262300A (en) Indolinylamide derivatives
AU1558300A (en) 1-cycloalkylpyrazoyl-benzoyl derivatives
AU2641899A (en) Heterocycle-fused benzothiazine derivatives
AU5239899A (en) Amidophosphate derivatives
AU4141099A (en) Pyrazolyldioxothiochromanoyl derivatives
AU2894099A (en) Phenanthrofuran derivatives
AU2028401A (en) 3-methyl-chromane or thiochromane derivatives
AU5666800A (en) Difuropyrone derivatives
AU2641299A (en) Benzofuran derivatives
AU1684300A (en) Cyclohexylpiperidine derivatives
AU2852199A (en) Benzothiazolone-7-sulfonamide derivatives

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase